Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome
<i>Background and objectives</i>: Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) has been recognized as the primary receptor for carbamylated low-density lipoproteins (cLDL) and is increasingly being viewed as a critical mediator of vascular inflammation and atherosclero...
Main Authors: | Teodora Stankova, Ginka Delcheva, Ana Maneva, Stefka Vladeva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/8/493 |
Similar Items
-
Serum Levels of Carbamylated LDL, Nitrotyrosine and Soluble Lectin-like Oxidized Low-density Lipoprotein Receptor-1 in Poorly Controlled Type 2 Diabetes Mellitus
by: Teodora R. Stankova, et al.
Published: (2019-09-01) -
Lectin-like, oxidized low-density lipoprotein receptor-1-deficient mice show resistance to age-related knee osteoarthritis
by: Kazuhiko Hashimoto, et al.
Published: (2017-02-01) -
LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis
by: Dimitry A. Chistiakov, et al.
Published: (2016-05-01) -
Oxidized Low-Density Lipoprotein-Deteriorated Psoriasis Is Associated with the Upregulation of Lox-1 Receptor and Il-23 Expression In Vivo and In Vitro
by: Chun-Ming Shih, et al.
Published: (2018-09-01) -
“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
by: Masahiro Miyawaki, et al.
Published: (2018-07-01)